International Headache Genetics Consortium (IHGC) Finland
Research
Date range: 1 December 2022 - 30 November 2023
Research collaboration: International Headache Genetics Consortium (IHGC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
International Headache Genetics Consortium (IHGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- 23andMe, Inc.
- Autonomous University of Barcelona (UAB)
- Biomedical Research Networking Center on Rare Diseases (CIBERER)
- Brigham and Women's Hospital (BWH)
- Erasmus University Medical Center (Erasmus MC)
- Folkhälsan Research Center
- Harvard University
- Helsinki University Central Hospital (HUCH)
- Institute for Molecular Medicine Finland (FIMM)
- Karolinska Institute (KI)
- King's College London (KCL)
- Leiden University Medical Center (LUMC)
- Massachusetts General Hospital (MGH)
- Max Planck Institute of Psychiatry
- NIH National Institute on Aging (NIA)
- QIMR Berghofer Medical Research Institute
- St George's, University of London (SGUL)
- Sutter Health
- Tampere University
- Ulm University
- University Hospital of Munich (KUM), LMU
- University Medical Center Hamburg-Eppendorf (UKE), UHH
- University of Barcelona (UB)
- University of Bristol (UoB)
- University of Copenhagen (UCPH)
- University of Helsinki
- University of Oslo (UiO)
- University of Oulu
- University of Tartu (UT)
- University of Turku (UTU)
- University of Tübingen (Uni Tübingen)
- VU Amsterdam
- Vall d'Hebron Research Institute (VHIR), HUVH ICS
- Vall d'Hebron University Hospital (HUVH), ICS
- Wellcome Trust Genome Campus
- deCODE Genetics, Inc.